In this article, we will list the 5 Stocks to Buy on a Pullback. Please visit 10 Stocks to Buy on a Pullback if you would like to see the extended list and the methodology behind it.
5. GFL Environmental Inc. (NYSE:GFL)
On April 16, 2026, Stifel analyst Shlomo Rosenbaum lowered the price target on GFL Environmental Inc. (NYSE:GFL) to C$65 from C$84 while maintaining a Buy rating on the shares. The firm said the company’s investment narrative is shifting following its acquisition of Secure Waste Infrastructure and expects the stock to trade at an EV/EBITDA discount relative to solid waste peers.
On April 14, 2026, Citi also reduced its price target on GFL Environmental Inc. (NYSE:GFL) to $51 from $55 previously but kept a Buy rating, describing the Secure Waste deal as mixed overall. The firm added that the stock appears oversold.
Earlier in April, GFL Environmental Inc. (NYSE:GFL) announced it would acquire Secure Waste Infrastructure in a transaction valued at approximately C$6.4B, including debt, to expand its footprint in Western Canada. Under the terms, GFL will purchase all outstanding shares of Secure Waste for C$24.75 per share, funded through a mix of 20% cash and 80% stock.
GFL Environmental Inc. (NYSE:GFL) provides non-hazardous solid waste management services across Canada and the United States.
4. Antero Resources Corporation (NYSE:AR)
On April 20, 2026, Siebert Williams analyst Gabriele Sorbara raised the price target on Antero Resources Corporation (NYSE:AR) to $56 from $50 previously and maintained a Buy rating on the shares.
On April 16, 2026, Morgan Stanley also lifted its price target to $56 from $54 and kept an Overweight rating ahead of Q1 results. The firm expects most exploration and production companies to hold activity levels steady despite stronger oil prices, noting that while the sector has given back its March gains, energy prices are unlikely to return to pre-conflict levels in the near term.
Earlier in the month, Jefferies raised its price target on Antero Resources to $54 from $50 and maintained a Buy rating, estimating Q1 free cash flow of about $434M, supported by strong commodity realizations.
Meanwhile, BMO Capital raised its price target to $50 from $40 while keeping a Market Perform rating, incorporating updated Q1 mark-to-market assumptions. The firm noted that Winter Storm Fern has supported near-term free cash flow, while geopolitical tensions have improved the outlook for LPG pricing. BMO also highlighted potential incremental gas demand tied to large-scale data center developments in West Virginia.
Antero Resources Corporation (NYSE:AR) explores and produces natural gas, NGLs, and oil in the United States.
3. Transocean Ltd. (NYSE:RIG)
On April 15, 2026, Transocean Ltd. (NYSE:RIG) announced that its Deepwater Asgard secured a five-well contract in the Eastern Mediterranean with an undisclosed operator. The campaign is expected to run for about 390 days, starting in Q4, and add approximately $158M to backlog, excluding additional services and mobilization-related fees. Including recent awards for the Transocean Barents in Norway and the Deepwater Orion, Deepwater Aquila, and Deepwater Corcovado in Brazil, total backlog additions since the start of April are estimated at around $1.6B.
On April 14, 2026, Morgan Stanley raised its price target on Transocean to $7 from $5 while maintaining an Equal Weight rating. The firm said higher oil prices, beyond ongoing Middle East disruptions, could support increased upstream spending, adding that its 2027–2028 EBITDA estimates are now roughly 6% above consensus across its energy services coverage.
Earlier in the month, Transocean announced a series of contract awards and extensions totaling about $1.0B in incremental backlog. These include a 1,095-day contract for the Transocean Barents with Var Energi in Norway at a day rate of $450,000, expected to begin in mid-2027 and contribute roughly $490M. The contract also includes options that could extend operations through 2034. In Brazil, the Deepwater Orion received a 1,095-day extension with Petrobras worth about $420M, keeping the rig contracted through March 2030, while the Deepwater Aquila secured a 365-day extension valued at approximately $160M, extending its commitment through June 2028.
Transocean Ltd. (NYSE:RIG) provides offshore drilling services for oil and gas exploration and development worldwide.
2. Comstock Resources, Inc. (NYSE:CRK)
On April 15, 2026, Citi analyst Scott Gruber lowered the price target on Comstock Resources, Inc. (NYSE:CRK) to $19 from $24 previously and maintained a Neutral rating on the shares. The firm updated its model ahead of earnings, projecting a discretionary cash flow of about $230.1M, slightly below the roughly $244.8M consensus, primarily due to more conservative commodity price assumptions. Citi also expects production to come in around the midpoint of guidance, with a modest sequential increase.
Last month, Comstock Resources, Inc. (NYSE:CRK) announced that its Western Haynesville operations will support the newly designated Texas Natural Gas-Fired Power Generation Hub in Anderson County, Texas. The project was selected by the U.S. Department of Commerce as part of Japan’s $550B investment commitment tied to the U.S.-Japan trade agreement. The development is a collaboration between Comstock and NextEra Energy (NYSE:NEE), which will build and operate the facility. The project is expected to deliver up to 5.2 GW of natural gas-fired capacity, capable of supporting roughly 5 GW of large-scale demand. Comstock is positioned to supply natural gas to the facility, with volumes potentially approaching 1 Bcf per day by 2031. The total project cost is estimated at $16B and remains subject to final agreements and development milestones.
Comstock Resources, Inc. (NYSE:CRK) explores, develops, and produces natural gas and oil assets in the United States.
1. AbbVie Inc. (NYSE:ABBV)
On April 20, 2026, Canaccord initiated coverage of AbbVie Inc. (NYSE:ABBV) with a Buy rating and a $262 price target on the shares, offering an upside potential of around 29% from AbbVie Inc. (NYSE:ABBV)’s last close.
On April 12, 2026, CollPlant disclosed that Allergan Industrie SAS, an AbbVie company, exercised its right to terminate a development agreement originally signed in February 2021, with termination taking effect after a 60-day notice period. The partnership had focused on developing dermal and soft tissue fillers using CollPlant’s rhCollagen technology for the medical aesthetics market. Despite the termination, CollPlant indicated it continues to see strong interest in its collagen platform and is actively pursuing new partnerships, including discussions with multiple strategic and Tier 1 companies for potential collaborations in aesthetic applications.
A day earlier, AbbVie Inc. (NYSE:ABBV) announced that late-breaking results from the Phase 2 IMGN853-0420 trial will be presented at the 2026 Society of Gynecologic Oncology Annual Meeting. The study evaluated mirvetuximab soravtansine-gynx (Elahere) in combination with carboplatin, followed by monotherapy maintenance, in patients with folate receptor alpha-positive, platinum-sensitive ovarian cancer. The trial enrolled 125 patients and focused on objective response rate as the primary endpoint, with additional measures including duration of response, progression-free survival, and overall survival.
AbbVie Inc. (NYSE:ABBV) develops and markets pharmaceutical therapies across multiple therapeutic areas globally.
While we acknowledge the potential of ABBV to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ABBV and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 10 Best Stocks That Beat Earnings Estimates and 10 Best 52-Week Low NASDAQ Stocks to Buy Now.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
